Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 38 (6) , 542-549
- https://doi.org/10.1016/0026-0495(89)90214-x
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Reduction of Serum Cholesterol in Heterozygous Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1983
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Therapeutic effects of ML-236B in primary hypercholesterolemiaAtherosclerosis, 1980
- Heterozygous familial hypercholesterolemiaAtherosclerosis, 1979
- Metabolic Studies in Familial HypercholesterolemiaJournal of Clinical Investigation, 1979
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974
- The metabolism of low density lipoprotein in familial type II hyperlipoproteinemiaJournal of Clinical Investigation, 1972
- RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATESThe Lancet, 1969
- Coronary Disease in Familial HypercholesterolemiaCirculation, 1967